AC Immune (ACIU) EBT Margin Growth (1y) (2016 - 2026)

AC Immune (ACIU) EBT Margin Growth (1y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,526.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,558.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -683.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 452.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 AC Immune 225.68 Mn 225.68 Mn - 59,942.00

Historic Data

Download Data
DateValue
Mar 31, 2026 59,942.00
Dec 31, 2025 -286,327.00
Sep 30, 2025 -171,041.00
Jun 30, 2025 169,052.00
Dec 31, 2020 19,548.00
Sep 30, 2020 -251,923.00
Jun 30, 2020 -33,479.00
Mar 31, 2020 -14,733.00
Dec 31, 2019 -95,180.00
Sep 30, 2019 141,424.00
Jun 30, 2019 -56,894.00
Mar 31, 2019 88,129.00
Dec 31, 2018 -133,911.00
Sep 30, 2018 29,292.00
Jun 30, 2018 99,142.00
Mar 31, 2018 -79,610.00
Dec 31, 2017 -82,548.00
Sep 30, 2017 -17,915.00
Mar 31, 2017 126,750.00
Dec 31, 2016 84,057.00